Tech Company Financing Transactions

Just Biotherapeutics Funding Round

Bill & Melinda Gates Foundation, Merck Capital Ventures and Arch Venture Partners participated in a $14 million Series A venture round for Just Biotherapeutics. This VC investment round was announced on 7/26/2016.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

401 Terry Ave. North
Seattle, WA 98109
USA

Phone

(206) 651-5094

Website

www.justbiotherapeutics.com

Email Address

[email protected]

Overview

Just is an integrated design company focused on the technology of biotherapeutics, from molecule to manufacturing plant. We believe that technological innovation will accelerate biotherapeutic development and dramatically reduce the cost of these vital medicines.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

James Thomas

        

Chief Operating Officer

Victor Fung

        

Chief Scientific Officer

Dean Pettit

        

VP - Bus. Development

Vasant Gandhi

        

VP - Bus. Development

Carolina Rizo

        

VP - Engineering

Brian Horman

        

VP - Human Resources

Caroline Chan

        

Browse more venture capital transactions:

Prev: 7/26/2016: Sun Basket venture capital transaction
Next: 7/26/2016: Videolicious venture capital transaction

Share this article

News on VC Transactions

Our team works diligently to record all VC transactions involving tech companies. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary